Press Releases Theralase® Patient Six Cancer-Free at Nine Months After Single Anti-Cancer TreatmentJanuary 30, 2019Theralase® Completes $1.4 M Private Placement Equity FinancingJanuary 09, 2019Health Canada Grants ITA Approval to Commence Phase II Clinical StudyDecember 10, 2018Theralase’s Rutherrin® Photo Dynamic Therapy Induces Immune Response to Destroy Human Brain Cancer CellsNovember 30, 2018Theralase® Release 3Q2018 Financial StatementsNovember 29, 2018Theralase® Granted Canadian Anti-Cancer PatentNovember 15, 2018Patient Five Cancer-Free After Single PDT TreatmentNovember 08, 2018Theralase® Anti-Cancer Technology Shows Promise for Esophageal Cancer Using Targeted Molecular Delivery SystemOctober 09, 2018Theralase® Announces Completion of Non-Brokered Private Placement for Approximately $1.1 millionOctober 03, 2018Health Canada Approves Commencement of Phase II Clinical StudySeptember 10, 2018Theralase’s® Lead Photodynamic Compound TLD-1433 Provides New Opportunities in Targeted Cancer TherapySeptember 04, 2018Theralase® Announces Proposed Non-Brokered Private Placement of up to $10 MillionAugust 28, 2018Theralase® Provides Corporate UpdateAugust 27, 2018Theralase® Submits Phase II Bladder Cancer Clinical Study Application to Health Canada for Review and ApprovalAugust 20, 2018Theralase® Achieves Exploratory Efficacy Endpoint in Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study for Patients Five and SixAugust 13, 2018Theralase® Releases 2Q2018 Financial StatementsJuly 26, 2018Theralase® Demonstrates Anti-Cancer Technology Prevents Recurrence of Bladder Cancer at 180 Days Post-TreatmentJuly 16, 2018Theralase® Releases AGM VideosJune 29, 2018Theralase® Strengthens Its Patent Portfolio with an Additional US Patent Covering Metal-Glycoprotein Complexes, Including Rutherrin® Based Photo Dynamic Therapy, in Immune Privileged SitesJune 22, 2018Theralase® Successfully Completes Phase Ib Non-Muscle Invasive Bladder Cancer Clinical StudyMay 30, 2018« Previous12345…11Next » We exhibit at .. Discover our Therapeutic Lasers Read our latest blog articles .. Developing a Potential Cure for Bladder Cancer Theralase – Participating in Bladder Cancer Walk 2019 Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment Active Rehabilitation – How Much is Too Much? Speeding up Athletes’ Recovery ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Theralase Laser Technology – The Magic Lamp? ✴ Guest blog post by Dr. JAMES W. GREGG, D.C. Treating Sports-Related Ankle Sprains Natural, Drug-free Pain Management ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Are Soccer Moms Now the Candidates Most Likely to Succumb to Drug Addiction? Everything You Need To Know About Class 3 vs. Class 4 123
